Glenmark Pharmaceuticals Ltd KYS Report: Ownership & Insights

15:59 Dec 12

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1975.00

+19.00 (+0.97%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

1975.00

+19.00 (+0.97%)

59/100 High Financial Strength

Quality

36/100 Mid Valuation

Valuation

64/100 Technically Moderately Bullish

Technical

SWOT

Strength

Weakness

Opportunity

Threat

55.73K

Market Cap (Cr)

55.19

PE Ratio

5.82

Price to Book Ratio

60.82

RSI

7.86 %

Net Profit Margin

Rating Based on 4 Analysts

Buy 50%

Hold 25%

Sell 25%

Buy

The consensus recommendation from 2 analysts for Glenmark Pharmaceuticals Ltd. is Buy

Analyst Price Target

The average price target is 2086.5 with a high estimate of 2306 and low estimate of 1570

High Average Low

Current 1975.00

2306.00

2086.50

1570.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password